Navigation Links
ViroPharma Launches 'Swell,' an Original Documentary Chronicling the Lives of People Living with Hereditary Angioedema
Date:5/26/2011

z, an allergist/immunologist at the Allergy Clinic of Tulsa in Tulsa, Okla. "Raising awareness of rare disorders is critically important, and may help in the diagnosis of the disease. In addition, a film like this can help assure those dealing with such a rare condition that they are not alone."

This film is one in a series of programs that demonstrates ViroPharma's commitment to raising awareness of hereditary angioedema and to supporting the rare disease community. All of these programs – including Swell -- can be accessed at HAEandME.com.

About Hereditary Angioedema

HAE is a rare, severely debilitating, life-threatening genetic disorder caused by a deficiency of C1 inhibitor, a human plasma protein. This condition is the result of a defect in the gene controlling the synthesis of C1 inhibitor. C1 inhibitor maintains the natural regulation of the contact, complement, and fibrinolytic systems, that when left unregulated, can initiate or perpetuate an attack by consuming the already low levels of endogenous C1 inhibitor in HAE patients. Patients with C1 inhibitor deficiency experience recurrent, unpredictable, debilitating, and potentially life threatening attacks of inflammation affecting the larynx, abdomen, face, extremities and urogenital tract. Patients with HAE experience approximately 20 to 100 days of incapacitation per year. There are estimated to be at least 6,500 people with HAE in the United States.

For more information on HAE, visit the U.S. HAE Association's website at: www.haea.org.

About ViroPharma Incorporated

ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing novel solutions for physician specialists to address unmet medical needs of patients living with diseases that have few if any clinical therapeutic options.  Our goal is to pro
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ViroPharma Initiates Phase 2 Study of VP 20621 for Prevention of Recurrence of Clostridium difficile Infection (CDI)
2. Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze® (C1 esterase inhibitor [human])
3. ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor
4. ViroPharma to Participate In Three May Healthcare Investor Conferences
5. ViroPharma to Release 2011 First Quarter Financial Results On April 28, 2011
6. ViroPharma Initiates Phase 2 Study of C1 Esterase Inhibitor [Human] for Treatment of Antibody-Mediated Rejection (AMR)
7. ViroPharma Launches HAE and Me, A New Online Community to Unite People Living With Hereditary Angioedema
8. ViroPharma Announces Positive CHMP Opinion for Cinryze® (C1 Inhibitor [Human]) in European Union
9. ViroPharma Announces Securities Repurchase Program
10. ViroPharma to Participate in Two March Healthcare Conferences
11. ViroPharma to Release 2010 Fourth Quarter and Full Year Financial Results on February 24, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... SAN DIEGO, July 31, 2014 Tandem Diabetes Care®, ... and manufacturer of the t:slim® Insulin Pump, today reported its ... In comparing the second quarter of 2014 to ... percent to $10.3 million from $5.5 million , t:slim ... pumps In comparing six months ended June 30, ...
(Date:7/31/2014)... , July 31, 2014  Alexza Pharmaceuticals, Inc. ... update on its pipeline and new product development ... to initiate a Phase 2a study of AZ-002 ... for the management of patients with acute repetitive ... Staccato -based product candidates for development - AZ-008 ...
(Date:7/31/2014)... July 31, 2014  Decision Resources Group is launching ... product Marketrack to now include ChinaTrack; the new capabilities ... in an interactive dashboard providing detailed brand-level share tracking ... a hospital level. Other key capabilities of ... feed: In addition to end-user surveys of healthcare facilities, ...
Breaking Medicine Technology:Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 2Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 3Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 4Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 5Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 6Alexza Provides Pipeline Update 2Alexza Provides Pipeline Update 3Alexza Provides Pipeline Update 4Alexza Provides Pipeline Update 5Alexza Provides Pipeline Update 6Decision Resources Group Announces First Medical Device Account Targeting Tool in China 2
(Date:7/31/2014)... THURSDAY, July 31, 2014 (HealthDay News) -- Transplant ... are red flags for burnout, a new study ... in the study reported having a low sense ... admitted to feeling emotionally exhausted, researchers found. ... specialties like transplantation," study co-author Dr. Marwan Abouljoud, ...
(Date:7/31/2014)... N.Y. (PRWEB) July 31, 2014 Joseph ... of the Hudson Valley (CDHV), a leading provider of ... the lower Hudson Valley. Dr. Lee is a ... cardiac electrophysiology. , In addition to his position ... at the New York-Presbyterian Hospital/ Columbia University Medical Center. ...
(Date:7/31/2014)... 31, 2014 Women in the Los ... of their financial future. The Independent Woman , ... registration for 6 upcoming Los Angeles area events. ... and with input from Kim Kiyosaki, a successful investor, ... Time) who is passionate about women’s financial education. , ...
(Date:7/31/2014)... rising steadily in the U.S in recent years. According ... the number of individuals reporting past year heroin use ... evidence suggests the increase may be linked to prescription ... PO use to heroin use, with POs providing the ... This drug-use trajectory appears to have become increasingly ...
(Date:7/31/2014)... Jersey (PRWEB) July 31, 2014 Clifton ... administer the application of topical fluoride treatments to their ... caries and help with tooth sensitivity in patients that ... is an infection that is commonly known as “tooth ... hard tissues of the teeth. , Fluoride ...
Breaking Medicine News(10 mins):Health News:Burnout Common Among Transplant Surgeons, Study Reveals 2Health News:ColumbiaDoctors of the Hudson Valley Welcomes Joseph M. Lee, M.D., M.S., R.P.V.I. 2Health News:ColumbiaDoctors of the Hudson Valley Welcomes Joseph M. Lee, M.D., M.S., R.P.V.I. 3Health News:The Independent Woman to Offer Financial Workshops in the Los Angeles Area - Developed by Women for Women 2Health News:NYU CDUHR researchers look at prescription opioid abuse among young adults in NYC 2Health News:NYU CDUHR researchers look at prescription opioid abuse among young adults in NYC 3Health News:NJ Top Dentists Approved, Clifton Dental Associates Now Actively Recommending the Application of Topical Fluoride Treatments to Adults 2
... in the United States will contract a sexually transmitted ... and Prevention. Experts believe a major contributing factor is ... and routinely. Now a new study provides some insight ... among teenagers. , Researchers from the Bradley ...
... Professional Postgraduate Services® (PPS®), renowned for its award-winning healthcare ... RSV and pediatric influenza, Preventing and Managing RSV Disease ... on PediatricRespiratory.org. , ... ...
... company, is thrilled to be included in Inc.,s 27th ... in the country. As the fastest growing company in ... to other healthcare staffing firms making the list it ... traveling healthcare staffing companies. It is the only company ...
... Universal,Health Services, Inc. (NYSE: UHS ) ... to sell Central Montgomery Medical Center, a 125 ... Abington Memorial,Hospital. The sale is subject to customary ... later this fall., UHS also announced that ...
... PITTSBURGH, Sept. 8 Mylan Inc. (NYSE: ... to market and other,conditions, $400 million principal amount ... offering to qualified institutional buyers pursuant,to Rule 144A ... (the "Securities,Act"). Mylan also expects to grant the ...
... spasms are a severe and potentially devastating epilepsy condition ... study appearing in Epilepsia, researchers have found ... diet more traditionally used for intractable childhood epilepsy, is ... The study is the first description of the ketogenic ...
Cached Medicine News:Health News:Teens' failure to use condoms linked to partner disapproval, fear of less sexual pleasure 2Health News:PediatricRespiratory.org Announces a Two-Part, Live CME/CE Webcast Series on RSV and Pediatric Influenza 2Health News:PediatricRespiratory.org Announces a Two-Part, Live CME/CE Webcast Series on RSV and Pediatric Influenza 3Health News:PediatricRespiratory.org Announces a Two-Part, Live CME/CE Webcast Series on RSV and Pediatric Influenza 4Health News:Medical Solutions Ranks No. 472 in the 2008 Inc. 500 with Three-Year Sales Growth of 667.8% 2Health News:Medical Solutions Ranks No. 472 in the 2008 Inc. 500 with Three-Year Sales Growth of 667.8% 3Health News:Medical Solutions Ranks No. 472 in the 2008 Inc. 500 with Three-Year Sales Growth of 667.8% 4Health News:Universal Health Services, Inc. Announces Sale of Acute Care Hospital and Addition of Two Behavioral Health Hospitals 2Health News:Mylan to Offer $400 Million in Cash Convertible Notes 2Health News:Mylan to Offer $400 Million in Cash Convertible Notes 3Health News:Diet may eliminate spasms for infants with epilepsy 2
Remote Alpha Dock system for the DNA Engine line, allows, Alpha unit to function remotely (requires fan power supply)...
Reads single TrakMates tubes instantly, and drops decoded tube number instantly into any Windows application. System includes reader and Windows based software....
Round, height-adjustable, steel laboratory stools with small footprint for small spaces • Choose options like different height-adjustment mechanism or paint finish. • your choice of color...
... acrylic panels mounted on powder-coated ... a free-standing modular cleanroom that ... 3. Optional ceiling HEPA filter/fan ... configured to customer requirements. Negative-pressure ...
Medicine Products: